108 related articles for article (PubMed ID: 1717849)
1. Dysmyelination in transgenic mice resulting from expression of class I histocompatibility molecules in oligodendrocytes.
Turnley AM; Morahan G; Okano H; Bernard O; Mikoshiba K; Allison J; Bartlett PF; Miller JF
Nature; 1991 Oct; 353(6344):566-9. PubMed ID: 1717849
[TBL] [Abstract][Full Text] [Related]
2. Dysmyelination in class I MHC transgenic mice.
Turnley AM; Morahan G
Microsc Res Tech; 1995 Nov; 32(4):286-94. PubMed ID: 8573778
[TBL] [Abstract][Full Text] [Related]
3. Major histocompatibility complex heavy chain accumulation in the endoplasmic reticulum of oligodendrocytes results in myelin abnormalities.
Baerwald KD; Corbin JG; Popko B
J Neurosci Res; 2000 Jan; 59(2):160-9. PubMed ID: 10650874
[TBL] [Abstract][Full Text] [Related]
4. Targeted CNS expression of interferon-gamma in transgenic mice leads to hypomyelination, reactive gliosis, and abnormal cerebellar development.
Corbin JG; Kelly D; Rath EM; Baerwald KD; Suzuki K; Popko B
Mol Cell Neurosci; 1996 May; 7(5):354-70. PubMed ID: 8812062
[TBL] [Abstract][Full Text] [Related]
5. Transgenic mice expressing polyoma virus large T antigen in astrocytes develop severe dysmyelination of the central nervous system.
Baron-Van Evercooren A; Jensen NA; Wyss MT; Cuzin F; Rassoulzadegan M; Brucher JM; Baron H
Lab Invest; 1992 Jan; 66(1):39-53. PubMed ID: 1309929
[TBL] [Abstract][Full Text] [Related]
6. Expression of the neu oncogene under the transcriptional control of the myelin basic protein gene in transgenic mice: generation of transformed glial cells.
Hayes C; Kelly D; Murayama S; Komiyama A; Suzuki K; Popko B
J Neurosci Res; 1992 Jan; 31(1):175-87. PubMed ID: 1377283
[TBL] [Abstract][Full Text] [Related]
7. Dysmyelination and reduced myelin basic protein gene expression by oligodendrocytes of SHP-1-deficient mice.
Massa PT; Wu C; Fecenko-Tacka K
J Neurosci Res; 2004 Jul; 77(1):15-25. PubMed ID: 15197735
[TBL] [Abstract][Full Text] [Related]
8. Major histocompatibility complex class I expression in oligodendrocytes induces hypomyelination in transgenic mice.
Power C; Kong PA; Trapp BD
J Neurosci Res; 1996 Apr; 44(2):165-73. PubMed ID: 8723225
[TBL] [Abstract][Full Text] [Related]
9. Expression and induction of intercellular adhesion molecules (ICAMs) and major histocompatibility complex (MHC) antigens on cultured murine oligodendrocytes and astrocytes.
Satoh J; Kim SU; Kastrukoff LF; Takei F
J Neurosci Res; 1991 May; 29(1):1-12. PubMed ID: 1909379
[TBL] [Abstract][Full Text] [Related]
10. Cell type-specific regulation of major histocompatibility complex (MHC) class I gene expression in astrocytes, oligodendrocytes, and neurons.
Massa PT; Ozato K; McFarlin DE
Glia; 1993 Jul; 8(3):201-7. PubMed ID: 8225560
[TBL] [Abstract][Full Text] [Related]
11. Detailed in vivo analysis of interferon-gamma induced major histocompatibility complex expression in the the central nervous system: astrocytes fail to express major histocompatibility complex class I and II molecules.
Horwitz MS; Evans CF; Klier FG; Oldstone MB
Lab Invest; 1999 Feb; 79(2):235-42. PubMed ID: 10068211
[TBL] [Abstract][Full Text] [Related]
12. Non-MHC-restricted cell-mediated lysis of human oligodendrocytes in vitro: relation with CD56 expression.
Antel JP; McCrea E; Ladiwala U; Qin YF; Becher B
J Immunol; 1998 Feb; 160(4):1606-11. PubMed ID: 9469416
[TBL] [Abstract][Full Text] [Related]
13. Distinct hypomyelinated phenotypes in MBP-SV40 large T transgenic mice.
Jensen NA; Smith GM; Shine HD; Garvey JS; Hood L
J Neurosci Res; 1993 Feb; 34(3):257-64. PubMed ID: 7681114
[TBL] [Abstract][Full Text] [Related]
14. Induction of experimental autoimmune encephalomyelitis in transgenic mice expressing ovalbumin in oligodendrocytes.
Cao Y; Toben C; Na SY; Stark K; Nitschke L; Peterson A; Gold R; Schimpl A; Hünig T
Eur J Immunol; 2006 Jan; 36(1):207-15. PubMed ID: 16342234
[TBL] [Abstract][Full Text] [Related]
15. Selective loss of mouse embryos due to the expression of transgenic major histocompatibility class I molecules early in embryogenesis.
Aït-Azzouzene D; Langkopf A; Cohen J; Bleux C; Gendron MC; Kanellopoulos-Langevin C
Mol Reprod Dev; 1998 May; 50(1):35-44. PubMed ID: 9547508
[TBL] [Abstract][Full Text] [Related]
16. Normal CNS myelination in transgenic mice overexpressing MHC class I H-2L(d) in oligodendrocytes.
Fuss B; Afshari FS; Colello RJ; Macklin WB
Mol Cell Neurosci; 2001 Aug; 18(2):221-34. PubMed ID: 11520182
[TBL] [Abstract][Full Text] [Related]
17. MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocyutes.
Herkel J; Jagemann B; Wiegard C; Lazaro JF; Lueth S; Kanzler S; Blessing M; Schmitt E; Lohse AW
Hepatology; 2003 May; 37(5):1079-85. PubMed ID: 12717388
[TBL] [Abstract][Full Text] [Related]
18. CD44 overexpression by oligodendrocytes: a novel mouse model of inflammation-independent demyelination and dysmyelination.
Tuohy TM; Wallingford N; Liu Y; Chan FH; Rizvi T; Xing R; Bebo B; Rao MS; Sherman LS
Glia; 2004 Sep; 47(4):335-45. PubMed ID: 15293231
[TBL] [Abstract][Full Text] [Related]
19. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L
Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
[TBL] [Abstract][Full Text] [Related]
20. PLP overexpression perturbs myelin protein composition and myelination in a mouse model of Pelizaeus-Merzbacher disease.
Karim SA; Barrie JA; McCulloch MC; Montague P; Edgar JM; Kirkham D; Anderson TJ; Nave KA; Griffiths IR; McLaughlin M
Glia; 2007 Mar; 55(4):341-51. PubMed ID: 17133418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
